NOSOCOMIAL IMPACTS GENERATED BY Acinetobacter baumannii: Literature review

• DOI: 10.22533/at.ed.1593132318026

• Palavras-chave: Acinetobacter baumannii; Hand Hygiene; Drug Resistance; Cross Infection

• Keywords: Acinetobacter baumannii; Hand Hygiene; Drug Resistance; Cross Infection

• Abstract:

  The incidence of Acinetobacter baumannii in the hospital sphere is a worldwide concern, since it is a multiresistant bacterium that represents an impasse in the health area due to the lack of sufficient antibiotics to attenuate it, in addition to making nosocomial treatment difficult. A. baumannii was the first bacterium, along with Pseudomonas aeruginosa, responsible for intra-hospital infections. In the context of Latin America, it has an incidence of 50% in Brazil and Argentina, which leads to an endemic characterization of the pathology. In addition, this bacterium fits the acronym “ESKAPE” referring to the main pathogenic and multiresistant bacteria, namely: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.

  Acinetobacter baumannii is a gram-negative bacterium, of high pathogenicity and virulence, aerobic, non-fermentative, frequent in humans and decomposing in soils. This causes more frequent opportunistic infections in moist tissues, such as mucous membranes, skin and respiratory and urinary tracts, which are installed in immunosuppressed organisms after surgery or in diseases under hospital treatment.